PL1830850T3 - Pochodne chinoliny do leczenia gruźlicy utajonej - Google Patents

Pochodne chinoliny do leczenia gruźlicy utajonej

Info

Publication number
PL1830850T3
PL1830850T3 PL05815816T PL05815816T PL1830850T3 PL 1830850 T3 PL1830850 T3 PL 1830850T3 PL 05815816 T PL05815816 T PL 05815816T PL 05815816 T PL05815816 T PL 05815816T PL 1830850 T3 PL1830850 T3 PL 1830850T3
Authority
PL
Poland
Prior art keywords
treatment
quinoline derivatives
latent tuberculosis
tuberculosis
latent
Prior art date
Application number
PL05815816T
Other languages
English (en)
Inventor
Koenraad Jozef Lodewijk Marcel Andries
Anil Koul
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35717702&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1830850(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PL1830850T3 publication Critical patent/PL1830850T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL05815816T 2004-12-24 2005-12-08 Pochodne chinoliny do leczenia gruźlicy utajonej PL1830850T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04078529 2004-12-24
EP05105008 2005-06-08
PCT/EP2005/056594 WO2006067048A1 (en) 2004-12-24 2005-12-08 Quinoline derivatives for the treatment of latent tuberculosis
EP05815816A EP1830850B1 (en) 2004-12-24 2005-12-08 Quinoline derivatives for the treatment of latent tuberculosis

Publications (1)

Publication Number Publication Date
PL1830850T3 true PL1830850T3 (pl) 2011-07-29

Family

ID=35717702

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05815816T PL1830850T3 (pl) 2004-12-24 2005-12-08 Pochodne chinoliny do leczenia gruźlicy utajonej

Country Status (30)

Country Link
US (1) US20060142279A1 (pl)
EP (1) EP1830850B1 (pl)
CN (1) CN103142595B (pl)
AP (1) AP2327A (pl)
AR (1) AR051790A1 (pl)
AT (1) ATE501721T1 (pl)
AU (1) AU2005242138B2 (pl)
BR (1) BRPI0506400B8 (pl)
CA (1) CA2529265C (pl)
CR (1) CR9267A (pl)
CY (1) CY1112247T1 (pl)
DE (1) DE602005026984D1 (pl)
DK (1) DK1830850T3 (pl)
EE (1) EE05394B1 (pl)
HR (1) HRP20110392T1 (pl)
IL (1) IL184123A (pl)
LV (1) LV13469B (pl)
ME (1) ME01207B (pl)
MY (1) MY145845A (pl)
NI (1) NI200700146A (pl)
NO (1) NO340376B1 (pl)
NZ (1) NZ555460A (pl)
PA (1) PA8654801A1 (pl)
PL (1) PL1830850T3 (pl)
PT (1) PT1830850E (pl)
RS (1) RS51730B (pl)
SI (1) SI1830850T1 (pl)
TR (1) TR200504892A1 (pl)
TW (1) TWI404535B (pl)
WO (1) WO2006067048A1 (pl)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1527050E (pt) * 2002-07-25 2010-06-22 Janssen Pharmaceutica Nv Derivados de quinolina e sua utilização como inibidores de micobactérias
CA2612614C (en) * 2005-06-28 2017-07-25 Janssen Pharmaceutica N.V. Quinoline derivatives as antibacterial agents
JO3270B1 (ar) * 2005-06-28 2018-09-16 Janssen Pharmaceutica Nv مشتقات كوينولين بصفة عوامل مضادة للبكتيريا
JO2752B1 (en) * 2005-06-28 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO2725B1 (en) * 2006-12-06 2013-09-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2970B1 (en) * 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO3271B1 (ar) * 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
CA2711912A1 (en) * 2008-01-14 2009-07-23 Jyoti Chattopadhyaya Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents
RU2404971C2 (ru) * 2008-12-02 2010-11-27 ЗАО "Фарм-Синтез" Новые производные хинолина, способ их получения, их применение для лечения микобактериальных инфекций, фармацевтическая композиция на их основе
US8741917B2 (en) 2009-01-15 2014-06-03 Rutgers, The State University Of New Jersey Benzo [C] phenanthridines as antimicrobial agents
US20120059026A1 (en) 2009-04-30 2012-03-08 University Of Medicine And Dentistry Of New Jersey Antimicrobial agents
WO2011156626A1 (en) 2010-06-09 2011-12-15 Rutgers, The State University Of New Jersey Antimicrobial agents
CA2803890A1 (en) 2010-06-25 2011-12-29 Rutgers, The State University Of New Jersey Antimicrobial agents
WO2013106756A2 (en) 2012-01-13 2013-07-18 Rutgers, The State University Of New Jersey Antimicrobial agents
AU2013235038A1 (en) 2012-03-21 2014-10-09 Malvika Kaul Antimicrobial agents
KR102110366B1 (ko) 2012-04-27 2020-05-14 얀센 파마슈티카 엔.브이. 항균성 퀴놀린 유도체
US9133167B2 (en) 2012-04-27 2015-09-15 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
US9458150B2 (en) 2013-11-08 2016-10-04 Rutgers, The State University Of New Jersey Antimicrobial agents
CN114129526A (zh) 2015-01-27 2022-03-04 詹森药业有限公司 可分散组合物
CN109195957A (zh) 2016-02-25 2019-01-11 塔克西斯医药股份有限公司 合成方法和中间体
EA201891644A1 (ru) * 2016-03-07 2019-04-30 Зе Глобал Эллайенс Фо Тб Драг Девелопмент, Инк. Антибактериальные соединения и их применение
RU2629369C1 (ru) * 2016-10-05 2017-08-29 Федеральное Государственное Унитарное Предприятие "Государственный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Химических Реактивов И Особо Чистых Химических Веществ" Четвертичные аммонийные производные 2-аминотиофен-3-карбоксилатов, обладающие противотуберкулезной активностью
CA3058183A1 (en) 2017-03-30 2018-10-04 Taxis Pharmaceuticals, Inc. Synthetic processes and synthetic intermediates towardthe production of txa709
WO2019012100A1 (en) 2017-07-14 2019-01-17 Janssen Pharmaceutica Nv EXTENDED ACTION FORMULATIONS
RU2661151C1 (ru) * 2017-12-14 2018-07-12 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Селективные ингибиторы глицеральдегид-3-фосфатдегидрогеназы микобактерий
KR20210113628A (ko) 2019-01-09 2021-09-16 얀센 파마슈티카 엔.브이. 비결핵성 마이코박테리아 질환의 치료에서의 조합물
WO2022008643A1 (en) 2020-07-09 2022-01-13 Janssen Pharmaceutica Nv Long-acting formulations
EP4178541A1 (en) 2020-07-09 2023-05-17 JANSSEN Pharmaceutica NV Long-acting formulations
KR20230107275A (ko) 2020-11-12 2023-07-14 얀센 파마슈티카 엔.브이. 비결핵성 마이코박테리아 질환의 치료에서 베다퀼린, 에탐부톨 및 마크롤라이드의 조합물
WO2023232838A1 (en) 2022-05-31 2023-12-07 Janssen Pharmaceutica Nv Bedaquiline for use in the treatment of leprosy
WO2024068693A1 (en) 2022-09-28 2024-04-04 Janssen Pharmaceutica Nv Long-acting formulations
CN119968203A (zh) 2022-09-28 2025-05-09 詹森药业有限公司 长效配制品
CN121941498A (zh) 2023-09-28 2026-04-28 詹森药业有限公司 用于治疗非结核分枝杆菌的atp合酶抑制剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
PT1527050E (pt) * 2002-07-25 2010-06-22 Janssen Pharmaceutica Nv Derivados de quinolina e sua utilização como inibidores de micobactérias

Also Published As

Publication number Publication date
ME01207B (me) 2013-03-20
MY145845A (en) 2012-04-30
CA2529265C (en) 2014-02-11
US20060142279A1 (en) 2006-06-29
CR9267A (es) 2008-09-09
EP1830850B1 (en) 2011-03-16
HK1186125A1 (en) 2014-03-07
AP2327A (en) 2011-11-25
NZ555460A (en) 2008-11-28
EE200500033A (et) 2006-08-15
PT1830850E (pt) 2011-05-31
NO340376B1 (no) 2017-04-10
IL184123A0 (en) 2008-12-29
TR200504892A1 (tr) 2010-04-21
TW200637551A (en) 2006-11-01
RS51730B (sr) 2011-10-31
NO20073823L (no) 2007-07-23
CY1112247T1 (el) 2015-12-09
SI1830850T1 (sl) 2011-07-29
AU2005242138B2 (en) 2011-05-26
NI200700146A (es) 2019-05-10
BRPI0506400B1 (pt) 2021-04-06
CN103142595B (zh) 2015-05-06
EP1830850A1 (en) 2007-09-12
WO2006067048A1 (en) 2006-06-29
IL184123A (en) 2011-10-31
CA2529265A1 (en) 2006-06-24
BRPI0506400A8 (pt) 2017-09-12
ATE501721T1 (de) 2011-04-15
BRPI0506400A (pt) 2006-08-29
HRP20110392T1 (hr) 2011-06-30
TWI404535B (zh) 2013-08-11
AP2007004054A0 (en) 2007-06-30
CN103142595A (zh) 2013-06-12
DK1830850T3 (da) 2011-06-14
AU2005242138A1 (en) 2006-07-13
EE05394B1 (et) 2011-04-15
AR051790A1 (es) 2007-02-07
LV13469B (en) 2007-01-20
PA8654801A1 (es) 2006-08-03
BRPI0506400B8 (pt) 2021-05-25
DE602005026984D1 (de) 2011-04-28

Similar Documents

Publication Publication Date Title
IL184123A0 (en) Quinoline derivatives for the treatment of latent tuberculosis
AP2037A (en) Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
PT1802579E (pt) Derivados da 3-arilaminopiridina
IL181524A0 (en) Heterocyclic compounds and methods of use
IL176629A0 (en) Sulfonamide derivatives for the treatment of diseases
AP2006003705A0 (en) Quinoline derivatives for use as mycobacterial inhibitors
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
IL177232A0 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
ZA200703884B (en) S-mirtazapine for the treatment of hot flush
IL180721A0 (en) Nicotinic receptor agonists for the treatment of inflammatory diseases
ZA200705160B (en) Quinoline derivatives for the treatment of latent tuberculosis
EP1750698A4 (en) 5-ANILINO-4-HETEROARYLPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES
IL179670A0 (en) Heterocyclic compounds and processes for the preparation thereof
ZA200800921B (en) Pyrazolone derivatives for the treatment of tuberculosis
PL1727545T3 (pl) Zastosowanie pochodnych N-piperydyny do leczenia patologii neurodegeneracyjnych
ZA200608015B (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
GB0408297D0 (en) Indole derivatives for the treatment of diseases
GB0412299D0 (en) Method for the synthesis of halogenated heterocycles
GB0406387D0 (en) Sulfonamide derivatives for the treatment of diseases
GB0406388D0 (en) Sulfonamide derivatives for the treatment of diseases
GB0224232D0 (en) Use of fluoroquinolone antibodies for the treatment of anthrax
PL372016A1 (pl) Sposób wytwarzania pochodnych N-fenylo-2-pirymidynoamin